54 related articles for article (PubMed ID: 2162582)
1. [Cytochrome P-450 and oxidative modification of macromolecules].
Archakov AI; Adrianov NV; Karuzina II
Vestn Akad Med Nauk SSSR; 1990; (2):21-7. PubMed ID: 2162582
[TBL] [Abstract][Full Text] [Related]
2. [Self-inactivation of cytochrome P-450 2B4 during catalytic cycle in the monooxygenase reconstituted system].
Zgoda VG; Karuzina II; Archakov AI
Vopr Med Khim; 1997; 43(4):217-25. PubMed ID: 9312936
[TBL] [Abstract][Full Text] [Related]
3. Two sites of azo reduction in the monooxygenase system.
Peterson FJ; Holtzman JL; Crankshaw D; Mason RP
Mol Pharmacol; 1988 Oct; 34(4):597-603. PubMed ID: 2845254
[TBL] [Abstract][Full Text] [Related]
4. [Oxidative modification of cytochrome P450 and other macromolecules during its turnover].
Archakov AI; Zgoda VG; Karuzina II
Vopr Med Khim; 1998; 44(1):3-27. PubMed ID: 9575609
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of azoreduction of dimethylaminoazobenzene by rat liver NADPH-cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and stimulation by FAD and FMN.
Levine WG; Raza H
Drug Metab Dispos; 1988; 16(3):441-8. PubMed ID: 2900738
[TBL] [Abstract][Full Text] [Related]
6. [Hydroxylation of aniline and aminoantipyrine derivatives (1-phenyl-2,3-dimethylaminopyrazolon-5) in liver endoplasmic reticulum].
Archakov AI; Karuzina II; Tveritinov VN; Kokareva IS
Biokhimiia; 1975; 40(1):32-9. PubMed ID: 1139001
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
[TBL] [Abstract][Full Text] [Related]
8. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
Murataliev MB; Feyereisen R
Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of elementary steps in the cytochrome P-450 reaction sequence. VI. Model treatment of the NADPH-dependent first electron transfer reaction between cytochrome P-450 reductase and cytochrome P-450 LM2 in solution.
Rohde K; Blanck J; Ruckpaul K
Biomed Biochim Acta; 1983; 42(6):651-62. PubMed ID: 6416251
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
11. [Effect of monooxygenase reactions catalyzed by cytochrome P-450 on the microsomal membrane].
Karuzina II; Mengazetdinov DE; Kapitanov AB; Zhukov AA; Ivanova LI
Biokhimiia; 1987 Jul; 52(7):1090-6. PubMed ID: 3663748
[TBL] [Abstract][Full Text] [Related]
12. Influence of cytochrome b5 on the stoichiometry of the different oxidative reactions catalyzed by liver microsomal cytochrome P-450.
Jansson I; Schenkman JB
Drug Metab Dispos; 1987; 15(3):344-8. PubMed ID: 2886309
[TBL] [Abstract][Full Text] [Related]
13. [Cytochrome P-450 distribution in endoplasmic reticulum membranes of rat liver].
Al'terman MA; Marekushev SA; Levchenko LA; Raevskiĭ AV; Devichenskiĭ VM
Biokhimiia; 1981 Feb; 46(2):222-9. PubMed ID: 7248379
[TBL] [Abstract][Full Text] [Related]
14. N-hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Possible relationship to the biological oxidation of arginine to NG-hydroxyarginine, citrulline, and nitric oxide.
Clement B; Jung F
Drug Metab Dispos; 1994; 22(3):486-97. PubMed ID: 8070328
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
[TBL] [Abstract][Full Text] [Related]
16. Oxidative cleavage of esters and amides to carbonyl products by cytochrome P450.
Peng HM; Raner GM; Vaz AD; Coon MJ
Arch Biochem Biophys; 1995 Apr; 318(2):333-9. PubMed ID: 7733661
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
Murataliev MB; Klein M; Fulco A; Feyereisen R
Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
[TBL] [Abstract][Full Text] [Related]
18. Triphenyltin acetate-mediated in vitro inactivation of rat liver cytochrome P-450.
Nebbia C; Ceppa L; Dacasto M; Carletti M
J Toxicol Environ Health A; 1999 Mar; 56(6):433-47. PubMed ID: 10096365
[TBL] [Abstract][Full Text] [Related]
19. [Oxidative modification of cytochrome P-450 during its function. II. Study of the mechanism of cytochrome P-450 LM2 inactivation in a soluble reconstructed monooxygenase system].
Tret'iakova LZ; Adrianov NV; Voronin EM; Dovgiĭ AI; Skotselias ED; Archakov AI
Biokhimiia; 1991 Jul; 56(7):1200-8. PubMed ID: 1932347
[TBL] [Abstract][Full Text] [Related]
20. [Inactivation of cytochrome P-450 in hydroxylase reactions].
Karuzina II; Archakov AI
Biokhimiia; 1985 Nov; 50(11):1805-10. PubMed ID: 4063403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
